Research output per year
Research output per year
Personal profile
External positions
Visiting PhD Student, Boston Children's Hospital
1 Mar 2023 → 31 Aug 2023
Fingerprint
Dive into the research topics where Kathrine Pedersen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
THE IMPORTANCE OF THE CD40-CD40L PATHWAY IN AUTOIMMUNITY
Pedersen, K., 5 Mar 2025Research output: Types of Thesis › PhD thesis
-
Treat-To-Target: Emergence of Second-Generation CD40L Inhibitors for Treatment of SLE-Identifying Beneficial Patient Candidates for CD40L Inhibitors in a Cross-Sectional SLE Cohort
Pedersen, K., Hansen, A. G., Palarasah, Y., Troldborg, A. & Thiel, S., Sept 2025, In: Scandinavian Journal of Immunology. 102, 3, 11 p., e70050.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Development of an immunoassay for quantification of soluble human CD40L (CD154) in plasma and serum samples
Pedersen, K., Laursen, N. S., Hansen, A. G., Palarasah, Y. & Thiel, S., Aug 2024, In: Journal of Immunological Methods. 531, 113710.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access1 Citation (Scopus) -
Gal-3 blocks the binding between PD-1 and pembrolizumab
Greisen, S. R., Bendix, M., Nielsen, M. A., Pedersen, K., Jensen, N. H., Hvid, M., Mikkelsen, J. H., Drace, T., Boesen, T., Steiniche, T., Schmidt, H. & Deleuran, B., 2 Oct 2024, In: Journal for Immunotherapy of Cancer. 12, 10, 12 p., e009952.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access1 Citation (Scopus) -
Galectin-3 interacts with PD-1 and counteracts the PD-1 pathway-driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis
Pedersen, K., Nielsen, M. A., Juul-Madsen, K., Hvid, M., Deleuran, B. W. & Greisen, S. R., Feb 2023, In: Scandinavian Journal of Immunology. 97, 2, 11 p., e13245.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open AccessFile11 Citations (Scopus)19 Downloads (Pure)